The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018)

Paul E. Greenberg,Andree-Anne Fournier,Tammy Sisitsky,Mark Simes,Richard Berman,Sarah H. Koenigsberg,Ronald C. Kessler
DOI: https://doi.org/10.1007/s40273-021-01019-4
2021-05-05
PharmacoEconomics
Abstract:The incremental economic burden of US adults with major depressive disorder (MDD) was estimated at $US210.5 billion in 2010 (year 2012 values).
pharmacology & pharmacy,health care sciences & services,health policy & services,economics
What problem does this paper attempt to address?